Roche Holding AG $RHHBY Shares Purchased by Yousif Capital Management LLC

Key Points

• Yousif Capital Management LLC increased its stake in Roche Holding AG by 7.8% during Q2, bringing its total holdings to 88,547 shares valued at approximately $3.59 million.
• Several hedge funds, including GAMMA Investing LLC and Riverbridge Partners LLC, have also significantly increased their holdings in Roche, indicating strong institutional interest in the stock.
• HSBC Global Research upgraded Roche from a "hold" to a "strong-buy" rating, setting a target price of $50.00, aligning with an overall positive sentiment from analysts towards the stock.

Yousif Capital Management LLC increased its stake in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 7.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 88,547 shares of the company's stock after acquiring an additional 6,395 shares during the period. Yousif Capital Management LLC's holdings in Roche were worth $3,593,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of RHHBY. GAMMA Investing LLC grew its holdings in Roche by 59.5% during the first quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock worth $529,000 after acquiring an additional 4,794 shares during the period. Riverbridge Partners LLC grew its holdings in Roche by 6.7% during the first quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock worth $1,557,000 after acquiring an additional 2,381 shares during the period. Altrius Capital Management Inc grew its holdings in Roche by 3.6% during the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after acquiring an additional 6,545 shares during the period. Moloney Securities Asset Management LLC grew its holdings in Roche by 53.8% during the first quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company's stock worth $1,672,000 after acquiring an additional 14,245 shares during the period. Finally, S&CO Inc. grew its holdings in Roche by 4.1% during the first quarter. S&CO Inc. now owns 51,199 shares of the company's stock worth $2,101,000 after acquiring an additional 2,014 shares during the period.

Analysts Set New Price Targets

Several analysts recently commented on RHHBY shares. Hsbc Global Res raised Roche from a "hold" rating to a "strong-buy" rating in a report on Thursday, October 2nd. HSBC raised Roche from a "hold" rating to a "buy" rating and set a $50.00 price objective on the stock in a report on Thursday, October 2nd. Three research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $50.00.

Roche Price Performance

Shares of RHHBY opened at $44.47 on Thursday. Roche Holding AG has a 12 month low of $34.10 and a 12 month high of $45.94. The stock's 50 day moving average is $41.67 and its two-hundred day moving average is $40.40.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.